Trial · NCT03643965
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Part A: Ratio of Urine Protein to Creatinine Ratio (UPCR) at 9 Months Compared to Baseline | 9 months | Full analysis set - global study - Part A | ratio | GEOMETRIC_LEAST_SQUARES_MEAN |
| PRIMARY | Part B: Time-weighted Average of Estimated Glomerular Filtration Rate (eGFR) | Up to 2 years and 1 month | Full analysis set - global study - Part B | mL/min/1.73m2 | GEOMETRIC_LEAST_SQUARES_MEAN |
| SECONDARY | Part A: Ratio of eGFR at 9 Months | 9 months | Full analysis set - global study - Part A | mL/min/1.73m2 | GEOMETRIC_LEAST_SQUARES_MEAN |
| SECONDARY | Part A: Ratio of eGFR at 12 Months | 12 months | Full analysis set - global study - Part A | mL/min/1.73m2 | GEOMETRIC_LEAST_SQUARES_MEAN |
| SECONDARY | Part A: Ratio of Urine Albumin to Creatinine Ratio (UACR) at 9 Months | 9 months | Full analysis set - global study - Part A | g/gram | GEOMETRIC_LEAST_SQUARES_MEAN |
| SECONDARY | Part B: Time to 30% Reduction in eGFR | Over 2 years | Full analysis set - global study - Part B | Participants | NUMBER |
| SECONDARY | Part B: Time to Receiving Rescue Medication. | Over 2 years | Full analysis set - global study - Part B | Participants | NUMBER |
| SECONDARY | Part B: Ratio of UPCR Compared to Baseline Averaged Over Time Points Between 12 and 24 Months | 12, 18 and 24 months | Full analysis set - global study - Part B | g/gram | GEOMETRIC_LEAST_SQUARES_MEAN |
| SECONDARY | Part B: Ratio of UACR Compared to Baseline Averaged Over Time Points Between 12 and 24 Months | 12 to 24 months | Full analysis set - global study - Part B | g/gram | GEOMETRIC_LEAST_SQUARES_MEAN |
| SECONDARY | Part B: Ratio of eGFR Compared to Baseline Averaged Over Time Points Between 12 and 24 Months | 12 to 24 months | Full analysis set - global study - Part B | mL/min/1.73m2 | GEOMETRIC_LEAST_SQUARES_MEAN |
| SECONDARY | Part B: Proportion of Patients Without Microhematuria | 12 to 24 months | Full analysis set - global study - Part B | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Part B: Short Form 36 (SF-36) Quality of Life Assessment at 9 Months. | 9 months | Full analysis set - global study - Part B | Percentage of total possible score | MEAN |
| SECONDARY | Part B: Short Form 36 (SF-36) Quality of Life Assessment at 24 Months. | 24 months | Full analysis set - global study - Part B | Percentage of total possible score | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03643965/outcomes